Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes

BACKGROUND: The criteria for metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) remain controversial. This research aimed to identify a potential biomarker to differentiate the subtypes of obesity. METHODS: The study conducted a lipidomic evaluation of ceramide in the seru...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Baowen, Hu, Moran, Jiang, Wanzi, Ma, Yizhe, Ye, Jingya, Wu, Qinyi, Guo, Wen, Sun, Yan, Zhou, Min, Xu, Yiwen, Wu, Zhoulu, Wang, Yiwen, Lam, Sin Man, Shui, Guanghou, Gu, Jingyu, Li, John Zhong, Fu, Zhenzhen, Gong, Yingyun, Zhou, Hongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548646/
https://www.ncbi.nlm.nih.gov/pubmed/37794463
http://dx.doi.org/10.1186/s12944-023-01921-0

Ejemplares similares

Ejemplares similares